AEST.MED.INT.HLD.SP.ADR/3 Tangible Net Worth Ratio
AEST.MED.INT.HLD.SP.ADR/3 tangible net worth ratio. AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€1.89 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 3FMA net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of AEST.MED.INT.HLD.SP.ADR/3 (2023–2024)
Tangible net worth ratio of AEST.MED.INT.HLD.SP.ADR/3 from 2023 to 2024. This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Tangible Net Worth Ratio has changed across 2 annual periods from 2023 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of €1.89 Million with intangible assets of €0.00 EUR. Check asset allocation strategy of AEST.MED.INT.HLD.SP.ADR/3 to assess the company's strategic physical and investment asset allocation.
AEST.MED.INT.HLD.SP.ADR/3 Tangible Net Worth Ratio by Year (2023–2024)
AEST.MED.INT.HLD.SP.ADR/3 tangible net worth ratio by year from 2023 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for AEST.MED.INT.HLD.SP.ADR/3 from 2023 to 2024, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 3FMA market cap.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 61.6% | €9.35 Million | €3.58 Million | €486.22 Million | ▼ -26.8 pp |
| 2023 | 88.5% | €33.63 Million | €3.88 Million | €560.66 Million | — |